WKYMVm-induced activation of formyl peptide receptor 2 stimulates ischemic neovasculogenesis by promoting homing of endothelial colony-forming cells

Stem Cells

Volumn 32, Issue 3, 2014, Pages 779-790

  Heo, Soon Chul ^a,b   Kwon, Yang Woo ^a,b   Jang, Il Ho ^a,b   Jeong, Geun Ok ^a,b   Yoon, Jung Won ^a,b   Kim, Chi Dae ^a,b   Kwon, Sang Mo ^b   Bae, Yoe Sik ^c   Kim, Jae Ho ^a,b,d  

^a MRC for Ischemic Tissue Regeneration   (South Korea)

^b Pusan National University School of Medicine   (South Korea)

^c Sungkyunkwan University   (South Korea)

^d Pusan National University Yangsan Hospital   (South Korea)

Author keywords

Endothelial colony forming cells; Formyl peptide receptor; Homing; Ischemia; Neovascularization

Indexed keywords

ENDOTHELIAL COLONY-FORMING CELLS; FORMYL PEPTIDE RECEPTOR; HOMING; ISCHEMIA; NEOVASCULARIZATION;

ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; COLONY-FORMING UNITS ASSAY; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; HINDLIMB; HUMANS; INJECTIONS, INTRAMUSCULAR; ISCHEMIA; LIMB SALVAGE; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NEOVASCULARIZATION, PHYSIOLOGIC; OLIGOPEPTIDES; PERFUSION; RECEPTORS, FORMYL PEPTIDE; RECOVERY OF FUNCTION;

EID: 84894251652     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1002/stem.1578     Document Type: Article

References (47)

1. Hooi JD, Stoffers HE, Knottnerus JA, et al. The prognosis of non-critical limb ischaemia: A systematic review of population-based evidence. Br J Gen Pract 1999; 49: 49-55.
2. Brevetti G, Giugliano G, Brevetti L, et al. Inflammation in peripheral artery disease. Circulation 2010; 122: 1862-1875.
3. Dormandy J, Heeck L, Vig S,. Predicting which patients will develop chronic critical leg ischemia. Semin Vasc Surg 1999; 12: 138-141.
4. Carmeliet P,. Angiogenesis in health and disease. Nat Med 2003; 9: 653-660.
5. Tongers J, Roncalli JG, Losordo DW,. Therapeutic angiogenesis for critical limb ischemia: Microvascular therapies coming of age. Circulation 2008; 118: 9-16.
6. Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275: 964-967.
7. Krenning G, van Luyn MJ, Harmsen MC,. Endothelial progenitor cell-based neovascularization: Implications for therapy. Trends Mol Med 2009; 15: 180-189.
8. Zampetaki A, Kirton JP, Xu Q,. Vascular repair by endothelial progenitor cells. Cardiovasc Res 2008; 78: 413-421.
9. Asahara T, Takahashi T, Masuda H, et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 1999; 18: 3964-3972.
10. Xu S, Zhu J, Yu L, et al. Endothelial progenitor cells: Current development of their paracrine factors in cardiovascular therapy. J Cardiovasc Pharmacol 2012; 59: 387-396.
11. Ingram DA, Caplice NM, Yoder MC,. Unresolved questions, changing definitions, and novel paradigms for defining endothelial progenitor cells. Blood 2005; 106: 1525-1531.
12. Ingram DA, Mead LE, Tanaka H, et al. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 2004; 104: 2752-2760.
13. Leone AM, Rutella S, Bonanno G, et al. Endogenous G-CSF and CD34+ cell mobilization after acute myocardial infarction. Int J Cardiol 2006; 111: 202-208.
14. Takahashi T, Kalka C, Masuda H, et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 1999; 5: 434-438.
15. Salcedo R, Wasserman K, Young HA, et al. Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: In vivo neovascularization induced by stromal-derived factor-1alpha. Am J Pathol 1999; 154: 1125-1135.
16. Hattori K, Dias S, Heissig B, et al. Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells. J Exp Med 2001; 193: 1005-1014.
17. Heeschen C, Aicher A, Lehmann R, et al. Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood 2003; 102: 1340-1346.
18. Vasa M, Fichtlscherer S, Adler K, et al. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 2001; 103: 2885-2890.
19. Le Y, Murphy, PM, Wang, JM,. Formyl-peptide receptors revisited. Trends Immunol 2002; 23: 541-548.
20. Ye RD, Boulay F, Wang JM, et al. International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family. Pharmacol Rev 2009; 61: 119-161.
21. Le Y, Hu, J, Gong, W, et al. Expression of functional formyl peptide receptors by human astrocytoma cell lines. J Neuroimmunol 2000; 111: 102-108.
22. VanCompernolle SE, Clark KL, Rummel KA, et al. Expression and function of formyl peptide receptors on human fibroblast cells. J Immunol 2003; 171: 2050-2056.
23. Rotrosen D, Malech HL, Gallin JI,. Formyl peptide leukocyte chemoattractant uptake and release by cultured human umbilical vein endothelial cells. J Immunol 1987; 139: 3034-3040.
24. Schiffmann E, Corcoran BA, Wahl SM,. N-formylmethionyl peptides as chemoattractants for leucocytes. Proc Natl Acad Sci USA 1975; 72: 1059-1062.
25. Baek SH, Seo JK, Chae CB, et al. Identification of the peptides that stimulate the phosphoinositide hydrolysis in lymphocyte cell lines from peptide libraries. J Biol Chem 1996; 271: 8170-8175.
26. Gao JL, Murphy PM,. Species and subtype variants of the N-formyl peptide chemotactic receptor reveal multiple important functional domains. J Biol Chem 1993; 268: 25395-25401.
27. Le Y, Gong, W, Li, B, et al. Utilization of two seven-transmembrane, G protein-coupled receptors, formyl peptide receptor-like 1 and formyl peptide receptor, by the synthetic hexapeptide WKYMVm for human phagocyte activation. J Immunol 1999; 163: 6777-6784.
28. Seo JK, Choi SY, Kim Y, et al. A peptide with unique receptor specificity: Stimulation of phosphoinositide hydrolysis and induction of superoxide generation in human neutrophils. J Immunol 1997; 158: 1895-1901.
29. Lee MS, Yoo SA, Cho CS, et al. Serum amyloid A binding to formyl peptide receptor-like 1 induces synovial hyperplasia and angiogenesis. J Immunol 2006; 177: 5585-5594.
30. Koczulla R, von Degenfeld G, Kupatt C, et al. An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. J Clin Invest 2003; 111: 1665-1672.
31. Rehman J, Li J, Orschell CM, et al. Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 2003; 107: 1164-1169.
32. Urbich C, Aicher A, Heeschen C, et al. Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. J Mol Cell Cardiol 2005; 39: 733-742.
33. Hur J, Yoon CH, Kim HS, et al. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol 2004; 24: 288-293.
34. Bae YS, Kim Y, Kim Y, et al. Trp-Lys-Tyr-Met-Val-D-Met is a chemoattractant for human phagocytic cells. J Leukoc Biol 1999; 66: 915-922.
35. Dufton N, Hannon R, Brancaleone V, et al. Anti-inflammatory role of the murine formyl-peptide receptor 2: Ligand-specific effects on leukocyte responses and experimental inflammation. J Immunol 2010; 184: 2611-2619.
36. Chiang N, Fierro IM, Gronert K, et al. Activation of lipoxin A(4) receptors by aspirin-triggered lipoxins and select peptides evokes ligand-specific responses in inflammation. J Exp Med 2000; 191: 1197-1208.
37. Kim SD, Kim YK, Lee HY, et al. The agonists of formyl peptide receptors prevent development of severe sepsis after microbial infection. J Immunol 2010; 185: 4302-4310.
38. Maeng YS, Choi HJ, Kwon JY, et al. Endothelial progenitor cell homing: Prominent role of the IGF2-IGF2R-PLCbeta2 axis. Blood 2009; 113: 233-243.
39. Lucerna M, Zernecke A, de Nooijer R, et al. Vascular endothelial growth factor-A induces plaque expansion in ApoE knock-out mice by promoting de novo leukocyte recruitment. Blood 2007; 109: 122-129.
40. Askari AT, Unzek S, Popovic ZB, et al. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 2003; 362: 697-703.
41. Su SB, Gong W, Gao JL, et al. A seven-transmembrane, G protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells. J Exp Med 1999; 189: 395-402.
42. De Y, Chen Q, Schmidt AP, et al. LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. J Exp Med 2000; 192: 1069-1074.
43. Pfosser A, El-Aouni C, Pfisterer I, et al. NF kappaB activation in embryonic endothelial progenitor cells enhances neovascularization via PSGL-1 mediated recruitment: Novel role for LL37. Stem Cells 2010; 28: 376-385.
44. Napoli C, Hayashi T, Cacciatore F, et al. Endothelial progenitor cells as therapeutic agents in the microcirculation: An update. Atherosclerosis 2011; 215: 9-22.
45. Soehnlein O, Wantha S, Simsekyilmaz S, et al. Neutrophil-derived cathelicidin protects from neointimal hyperplasia. Sci Transl Med 2011; 3: 103ra98.
46. Rodriguez MC, Cudic M,. Optimization of physicochemical and pharmacological properties of Peptide drugs by glycosylation. Methods Mol Biol 2013; 1081: 107-136.
47. Otvos L, Jr,. Peptide-based drug design: Here and now. Methods Mol Biol 2008; 494: 1-8.